Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Wednesday 22 October, 2014

GlaxoSmithKline PLC

Re Directorate

RNS Number : 0001V
GlaxoSmithKline PLC
22 October 2014





Change to Director's Details - Dr Moncef Slaoui


GlaxoSmithKline plc (the "Company") today confirms that Dr Moncef Slaoui, an Executive Director, is appointed Chairman, Vaccines, with immediate effect.


This appointment will ensure more focused management of the Company's Vaccines business in advance of the completion of the proposed 3 part transaction with Novartis announced earlier this year. Dr Slaoui will continue to provide scientific and technical counsel on pharmaceutical R&D activities to the CEO and Board.


Dr Slaoui was previously Chairman, Global R&D and Vaccines.



V A Whyte

Company Secretary


22 October 2014



This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t